Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001.

By L. Morton, Sophia S. Wang, S. Devesa, P. Hartge, D. Weisenburger, M. Linet. Blood, 2006

1,704 citations recorded by the source corpus.

Subfields: Genetics, Oncology, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/6aede0c7363cb8afaa78acfaa421d9bc19de7e70

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Genetics

1. A. Jemal

In Oncology

1. C. DeSantis
2. A. Jemal
3. R. Siegel
4. K. Miller

In Pathology and Forensic Medicine

1. A. Jemal

Citations in the corpus

• Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma (2017, methodology): “Staining was performed for 30 min on wet ice with the following commercially available fluorochrome-conjugated antibodies: (1) from BD Biosciences, PD1 phycoerytherin cyanine 7 (PE-Cy7) and CD57 Brilliant Violet 421 (BV421); (2) from BioLegend, CD3 (FITC), CCR7 (BV650), CD45RA (APC), CD4 (AF700), CD”
• 2016 US lymphoid malignancy statistics by World Health Organization subtypes (2016, background): “Classification changes and improved diagnostic tools have also been suggested as the explanation for increases in both marginal zone lymphoma and mantle cell lymphoma.(11) For marginal zone lymphoma, large, but nonsignificant, rate increases were seen in both sexes from 2000 to 2003, followed by mor”